Supporting these findings, insulin treatment decreased hepatic expression levels of NF-κB (Rel), Il-6 and Ccl2 in the NASH-STZ-HI hamster. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatohepatitis.